Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol

G. Milio; E. Corrado; C. Genova; C. Amato; F. Raimondi; P. L. Almasio; and S. Novo

首页> 外文期刊>Rheumatology >Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol

【24h】

Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol

机译：系统性硬化继发的雷诺氏病患者的伊洛前列素治疗和生活质量：一种新的治疗方案

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Objectives. To evaluate the clinical efficacy and the effects on the quality of life of iloprost, a prostacyclin analogue, used according to a new protocol in patients with Raynaud's phenomenon secondary to systemic sclerosis.

机译：目标。为了评估伊洛前列素伊洛前列素（一种前列环素类似物）的临床疗效以及对生活质量的影响，该药物根据新方案用于患有系统性硬化症继发性雷诺现象的患者。

著录项

来源
《Rheumatology》 |2006年第8期|999-1004|共6页
作者
G. Milio; E. Corrado; C. Genova; C. Amato; F. Raimondi; P. L. Almasio; and S. Novo;
展开▼
作者单位

Department of Internal Medicine and Cardiovascular Diseases and;

Department of Internal and Special Medicine University of Palermo Palermo Italy.;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol [J] . G. Milio, E. Corrado, C. Genova, Rheumatology . 2006,第8期

机译：系统性硬化继发的雷诺氏病患者的伊洛前列素治疗和生活质量：一种新的治疗方案
2. Antioxidant status after iloprost treatment in patients with Raynaud’s phenomenon secondary to systemic sclerosis [J] . Alexandra Balbir-Gurman, Yolanda Braun-Moscovici, Vladimir Livshitz, Clinical Rheumatology . 2007,第9期

机译：伊洛前列素治疗后系统性硬化继发雷诺现象患者的抗氧化状态
3. Antioxidant status after iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis. [J] . Balbir-Gurman A, Braun-Moscovici Y, Livshitz V, Clinical rheumatology . 2007,第9期

机译：瑞领患者中伊洛普斯特治疗后的抗氧化剂状态raynaud现象中次生患者。
4. Iloprost Treatment in Systemic Sclerosis – Effects on Autonomic Nervous System Assessed through Heart Rate Variability Parameters [C] . Elena Esmeralda Saramet, Doina-Clementina Cojocaru, Sorin Ungurianu, E-Health and Bioengineering Conference . 2020

机译：ILOPROST治疗在全身硬化 - 通过心率变异参数评估自主神经系统的影响
5. Meta-analysis of quality of life in those diagnosed with multiple sclerosis and Parkinson's disease following depression treatment. [D] . Ray, Karen A. 2010

机译：对抑郁症治疗后被诊断为多发性硬化症和帕金森氏病患者的生活质量进行荟萃分析。
6. Comparison of intravenous infusions of iloprost and oral nifedipine in treatment of Raynauds phenomenon in patients with systemic sclerosis: a double blind randomised study. [O] . M. Rademaker, E. D. Cooke, N. E. Almond, 1989

机译：依洛前列素和口服硝苯地平静脉输注治疗系统性硬化症患者的雷诺现象的比较：一项双盲随机研究。
7. Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol [O] . MILIO G, CORRADO E, GENOVA C, 2006

机译：系统性硬化继发的雷诺氏病患者的伊洛前列素治疗和生活质量：一种新的治疗方案

Iloprost treatment in patients with Raynaud's phenomenon secondary to systemic sclerosis and the quality of life: a new therapeutic protocol

摘要

著录项

相似文献

相关主题

期刊订阅